Login to Your Account


Chinese biopharmas eager to translate 'innovation' into drug approvals

By Marie Powers
Staff Writer

Thursday, May 8, 2014
SUZHOU, China ­– "Innovation" is a prominent theme in China's life sciences community, but for all the talk about the need to move from generics to novel drugs, focusing on the science without generating results is a wasted effort. That, in short, is a key message emerging from Chinese life science executives and research leaders at the Chinabio Partnering Forum.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription